1
Canaccord Genuity Limited Research Disclosures for Investment Companies
3IN.L 3i INFRASTRUCTURE 5
59KD.L Edinburgh IT 11.5% Deb Stk 2014 5
59KD.L Edinburgh IT 7.75% Deb Stk 2022 5
AAIF.L ABDN.ASIAN INCOME FUND 5
AAS.L ABDN.ASIAN SML 5
AIS.L ALTERNATIVE INVESTMENT STRATEGIES LIMITED 1a, 2, 4, 5, 7
ANW.L ABDN. NEW THAI INVESTMENT TRUST PLC 1a, 2, 4, 5, 7
ASL.L ABERFTH.SMLL.CO 5
ATR.L ASIAN TOTAL RETURN 5
ATST.L ALLIANCE TRUST 5
AUKT.L ABERDEEN UK TRACKER TRUST PLC 5
BABS.L BLUECREST ALLBLUE 5
BBGI.L BBGI 5
BC12.L BETTER CAPITAL 2012 CELL 5
BCAP.L BETTER CAPITAL 2009 CELL 5
BGFD.L BAILLIE G.JAP. 1A, 2, 4, 5, 7
BHGG.L BH GLOBAL LIMITED 5
BHME.L BH MACRO EUR 5
BHMG.L BH MACRO GBP 5
BHMU.L BH MACRO USD 5
BIOG.L BIOTECH GROWTH 5
BNKR.L BANKERS INV.TST 5
BRLA.L BLACKROCK LATIN AMERICA 5
BRNA.L BLACKROCK NORTH AMERICAN INCOME 5
BRNE.L BLACKROCK NEW ENERGY 5
BRNS.L BLACKROCK NEW ENERGY 5
BRSC.L BLACKROCK SMALLER COMPANIES TRUEST PLC 1a, 2, 4, 5, 7
BRWM.L BLACKROCK WORLD MINING 5
BSET.L BR.ASSETS TRUST 5
BSIF.L BLUEFIELD 5
BTEM.L BR.EMPIRE SEC. 5
CDI.L CANDOVER INVESTMENTS 5
CTY.L CITY OF LONDON 1a, 2, 3, 4, 5,7
DIVI.L DIVERSE INCOME TRUST 5
DNDL.L DUNEDIN SMALLERS. 5
DNE.L DUNEDIN ENTERPRISE 5
DPA.L DP AIRCRAFT 1 LIMITED 1a, 2, 3, 4, 5, 7
EDIN.L EDIN.INV.TRUST 1a, 2, 4, 5, 7
EFM.L EDINBURGH DRAGON 5
EPIC LN EDISTON PROPERTY 1a, 2, 3, 4, 5, 7
ELTA.L ELECTRA 5
EWI.L EDINBURGH WORLDWIDE 5
FAS.L FIDELITY ASIAN VALUES 1a, 2, 4, 5, 7
FCI.L F&C CAP&INC 5
FCS.L F&C GLOBAL SMALL 5
FCSS.L FIDELITY CHINA 5
FEV.L FIDELITY EUROPEAN VALUES 5
FGT.L FINSBURY GTH. 5
FJV.L FIDELITY JAPANESE VALUES PLC 1a, 2, 4, 5, 7
FPEO.L F&C PRIVATE EQUITY 5
FSC.L F&C US SMALLERS 5
FSV.L FIDELITY SPECIAL VALUES 5
GCPI.L GCP INFRASTRUCTURE 5
GPE.L GRAPHITE ENTERPRISE 5
GSS.L GENESIS EMERGING 5
HFEL.L HEND.FAR EAST 5
HGT.L HG CAPITAL 5
HICL.L HICL INF. 1a, 2, 3, 4, 5, 7
HRI.L HERALD INV 5
HSL.L HEND.SMALL 5
HSLE.L HARBOURVEST GLOBAL PRIVATE EQUITY ORD 5
HVPE.L HARBOURVEST GLOBAL PRIVATE EQUITY 5, 7
IEM.L IMPAX ENV.MKT 1a, 2, 4, 5, 7
INPP.L INTERNATIONAL PUBLIC PARTNERSHIPS 5
IPU.L INVESCO PERPETUAL SELECT TRUST PLC 1a, 2, 4, 5, 7
JAI.L JPMOR.ASIAN 5
JAM.L JPMOR.AMER. 5
JEO.L JUPITER EUROPE 5
JESC.L JPMORG.EUR ORD 5
JFJ.L JPMORG. JAPANESE IT 1a, 2, 4, 5, 7
JMIS.L JPMORG. SMALLER COMPANIES 5
JGC.L JUPITER GREEN 5
JLEN.L JOHN LAING ENVIRONMENTAL GROUP 5
JLIF.L JOHN LAING INF 5
JMF.L JPMORG. MID CAP IT 5
JMGS.L JPMORG EM 5
JMI.L JPMORG.SMALLER ORD 5
JMO.L JPMORG.OSEAS IT 5
JMOS JPMORG.OSEAS IT 5
JPEL.L JPMORGAN PRIVATE EQUITY 5
JPI.L JPMOR.I&C 5
JPIU.L JPMOR.I&C 5
JPIZ.L JPMOR.I&C PF 5
JPMORGAN INDIA 5
JPS.L JPMORG. JAPAN SMALLER COMPANIES IT 1a, 2, 4, 5, 7
JPMORGAN SENIOR SECURED 5
JUSC.L JPMORG.US ORD 5
JZCP.L JZ CAPITAL PARTNERS 5
LWI.L LOWLAND 5
MCP.L M.C.PACIFIC 5
3
MNKS.L MONKS INV.TST. 1a, 2, 4, 5, 7
MONTANARO EUROPEAN SMALLERS 5
MRC.L MERCANTILE 5
MRCH.L MERCHANTS TST 5
MXF.L MEDICX FUND 1a, 2, 3, 4, 5, 7
MYI.L MURRAY INTL.TST 5
NAIT.L NORTH AMERICAN INCOME TRUST 5
NBPE.L NB GLOBAL FLOATING RATE INCOME 5
NBPE.L NB PRIVATE EQUITY 5
NESF.L NEXTENERGY 5
PAC.L PACIFIC ASSETS TRUST P:C 1a, 2, 4, 5, 7
PCT.L POLAR CAPITAL TECHNOLOGY 5
PEY.L PRINCESS PRIVATE EQUITY 5
PHI.L PACIFIC HORIZON 5
PIN.L PANTHEON INTERNATIONAL ORD 1a, 2, 4, 5, 7
PINR.L PANTHEON INTERNATIONAL 1a, 2, 4, 5, 7
PLI.L PERPTL.I&G.INV. 5
PLIS.L PERPTL.I&G.SUB 5
PNL.L PERSONAL ASSETS 5
PTF.L PHAUNOS TIMBER 5
RCP.L RIT CAPITAL 5
RICA.L RUFFER INVESTMENT COMPANY 5
SCIN.L SCOTTISH IT 1a, 2, 4, 5, 7
SDU.L SCHRODER UK GROWTH 5
SEC.L STRATEGIC EQUITY CAPITAL PLC 1a, 2, 4, 5, 7
SEP.L STANDARD LIFE EUROPEAN PRIVATE EQUITY 1a, 2, 4, 5, 7
SLI.L STD LFE IN PTY 5
SLS.L STAND LIFE UK 5
SMT.L SCOTTISH MORTGAGE 5
SST.L SCOT.ORNTL.SMLL 5
SVI.L SVG CAPITAL 5
TEM.L TEMPLETON EMERGING 5
THRG.L BLACKROCK THROGMORTON 5
TRIG.L RENEWABLES INFRASTRUCTURE GROUP 1a, 2, 3, 4, 5, 7
UKT.L THREADNEEDLE UK SELECT TRUST LIMITED 1a, 2, 4, 5, 7
UKW.L GREENCOAT UK WIND 5
WPC.L WITAN PAC 5
WTAN.L WITAN INV TST 5
Research Disclosure Legend
1 Th The relevant issuer currently is, or in the past 12 months was, a client of Canaccord Genuity or its affiliated
companies. During this period, Canaccord Genuity or its affiliated companies provided the following services to the relevant issuer:
A. investment banking services.
B. non-investment banking securities-related services. C. non-securities related services.
2 In the past 12 months, Canaccord Genuity or its affiliated companies have received compensation for Corporate
Finance / Investment Banking services from the relevant issuer.
3 In the past 12 months, Canaccord Genuity or any of its affiliated companies have been lead manager, co-lead
manager or co-manager of a public offering of securities of the relevant issuer or any publicly disclosed offer of securities of the relevant issuer or in any related derivatives.
4 Canaccord Genuity acts as corporate broker for the relevant issuer and/or Canaccord Genuity or any of its affiliated
companies may have an agreement with the relevant issuer relating to the provision of Corporate Finance/Investment Banking services.
5 Canaccord Genuity or one or more of its affiliated companies is a market maker or liquidity provider in the
securities of the relevant issuer or in any related derivatives.
6 In the past 12 months, Canaccord Genuity, its partners, affiliated companies, officers or directors, or any authoring
analyst involved in the preparation of this research has provided services to the relevant issuer for remuneration, other than normal course investment advisory or trade execution services.
7 Canaccord Genuity or one or more of its affiliated companies intend to seek or expects to receive compensation for
Corporate Finance/Investment Banking services from the relevant issuer in the next six months.
8 The authoring analyst, a member of the authoring analyst’s household, or any individual directly involved in the
preparation of this research, has a long position in the shares or derivatives, or has any other financial interest in the relevant issuer, the value of which increases as the value of the underlying equity increases.
9 The authoring analyst, a member of the authoring analyst’s household, or any individual directly involved in the
preparation of this research, has a short position in the shares or derivatives, or has any other financial interest in the relevant issuer, the value of which increases as the value of the underlying equity decreases.
10 Those persons identified as the author(s) of this research, or any individual involved in the preparation of this
research, have purchased/received shares in the relevant issuer prior to a public offering of those shares, and such person’s name and details are disclosed above.
11 A partner, director, officer, employee or agent of Canaccord Genuity or its affiliated companies, or a member of
his/her household, is an officer, or director, or serves as an advisor or board member of the relevant issuer and/or one of its subsidiaries, and such person’s name is disclosed above.
12 As of the month end immediately preceding the date of publication of this research, or the prior month end if
publication is within 10 days following a month end, Canaccord Genuity or its affiliated companies, in the aggregate, beneficially owned 1% or more of any class of the total issued share capital or other common equity securities of the relevant issuer or held any other financial interests in the relevant issuer which are significant in relation to the research (as disclosed above).
13 As of the month end immediately preceding the date of publication of this research, or the prior month end if
publication is within 10 days following a month end, the relevant issuer owned 1% or more of any class of the total issued share capital in Canaccord Genuity or any of its affiliated companies.
14 Other specific disclosures as described above.
For the purposes of UK
For the purposes of UK regulation Canaccord Genuity Limited produces non-independent research which is a
marketing communication under the Financial Conduct Authority (FCA) Conduct of Business Rules and is not prepared in accordance with legal requirements designed to promote the independence of investment research, nor is it subject to any prohibition on dealing ahead of the dissemination of investment research. However, Canaccord Genuity Limited does have procedures in place to identify and manage conflicts of interest which may arise in the production of non-independent research, which include preventing dealing ahead and Information Barrier procedures.
5
For Canadian Residents:
This research has been approved by Canaccord Genuity Corp., which accepts sole responsibility for this research and its dissemination in Canada. Canaccord Genuity Corp. is registered and regulated by the Investment Industry Regulatory Organization of Canada (IIROC) and is a Member of the Canadian Investor Protection Fund. Canadian clients wishing to effect transactions in any designated investment discussed should do so through a qualified salesperson of Canaccord Genuity Corp. in their particular province or territory.
For United Kingdom and European Residents:
This research is for persons who are Eligible Counterparties or Professional Clients only and is exempt from the general restrictions in section 21 of the Financial Services and Markets Act 2000 (or any analogous legislation) on the
communication of invitations or inducements to engage in investment activity on the grounds that it is being distributed in the United Kingdom only to persons of a kind described in Article 19(5) (Investment Professionals) and 49(2) (High Net Worth companies, unincorporated associations etc) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended). It is not intended to be distributed or passed on, directly or indirectly, to any other class of persons. This material is not for distribution in the United Kingdom or Europe to retail clients, as defined under the rules of the Financial Conduct Authority.
For United States Residents:
This research is distributed by Canaccord Genuity Limited in the United States to “major US institutional investors”, as defined under Rule 15a-6 promulgated under the US Securities Exchange Act of 1934, as amended, and as interpreted by the staff of the US Securities and Exchange Commission (SEC). This research is also distributed in the United States to other institutional investors by Canaccord Genuity Inc., who accepts responsibility for the research, [subject to the qualifications stated in this publication which are hereby incorporated]. Canaccord Genuity Inc, at 350 Madison Avenue, 10th Floor, New York, NY 10017, is a registered broker-dealer with the SEC and is a member of FINRA. Nothing herein excludes or restricts any duty or liability to a customer that Canaccord Genuity Inc. has under any applicable law. Analyst(s) preparing this report are resident outside the United States and are not associated persons or employees of any US regulated broker-dealer. Therefore the analyst(s) may not be subject to Rule 2711 restrictions on communications with a subject company, public appearances and trading securities held by a research analyst account.
For Jersey, Guernsey and Isle of Man Residents:
This research is sent to you by Canaccord Genuity Wealth (International) Limited ("CGWI") for information purposes and is not to beconstrued as a solicitation or an offer to purchase or sell investments or related financial instruments. This research has been produced by an affiliate of CGWI for circulation to its institutional clients and also CGWI. Its contents have been approved by CGWI and we are providing it to you on the basis that we believe it to be of interest to you. This statement should be read in conjunction with your client agreement, CGWI's current terms of business and the other disclosures and
disclaimers contained within this research. If you are in any doubt, you should consult your financial adviser.
CGWI is licensed and regulated by the Guernsey Financial Services Commission, the Jersey Financial Services Commission and the Isle of Man Financial Supervision Commission. CGWI is registered in Guernsey and is a wholly owned subsidiary of Canaccord Genuity Group Inc.
For Australian Residents:
This research is distributed in Australia by Canaccord Genuity Limited. Under ASIC Class Order (CO 03/1099), Canaccord Genuity Limited is exempt from the requirement to hold an Australian financial services licence for the provision of its
financial services to you. Canaccord Genuity Limited is authorised and regulated by the Financial Conduct Authority under the laws of the United Kingdom which differ from Australian laws. This research is provided to you on the basis that you are a 'wholesale client' within the meaning of section 761G of the Corporations Act 2001 (Cth). To the extent that this research contains any advice, this is limited to general advice only. Recipients should take into account their own personal circumstances before making an investment decision. Clients wishing to effect any transactions in any financial products discussed in this research should do so through a qualified representative of Canaccord Genuity (Australia) Limited AFS Licence No 234666.
For Singapore Residents:
This research is distributed pursuant to 32C of the Financial Advisers under an arrangement between each of the Canaccord Genuity entities that publish research and Canaccord Genuity Singapore Pte. Ltd who is an exempt financial adviser under section 23(1)(d) of the Financial Advisers Act. This research is only intended for persons who fall within the definition of accredited investor, expert investor or institutional investor as defined under section 4A of the Securities and Futures Act. It is
not intended to be distributed or passed on, directly or indirectly, to any other class of persons. Recipients of this report can contact Canaccord Genuity Singapore Pte. Ltd. (Contact Tel: +65 6854 6150) in respect of any matters arising from, or in connection with, the research.
For Hong Kong Residents:
This research is distributed in Hong Kong by Canaccord Genuity (Hong Kong) Limited which is licensed by the Securities and Futures Commission. This research is only intended for persons who fall within the definition of professional investor as defined in the Securities and Futures Ordinance. It is not intended to be distributed or passed on, directly or indirectly, to any other class of persons. Recipients of this report can contact Canaccord Genuity (Hong Kong) Limited. (Contact Tel: +852 3919 2561) in respect of any matters arising from, or in connection with, this research.
Additional information is available on request.
Copyright © Canaccord Genuity Corp. 2015. – Member IIROC/Canadian Investor Protection Fund
Copyright © Canaccord Genuity Limited 2015. – Member LSE, authorized and regulated by the Financial Conduct Authority. Copyright © Canaccord Genuity Inc. 2015. – Member FINRA/SIPC
Copyright © Canaccord Genuity (Australia) Limited 2015. – Participant of ASX Group, Chi-x Australia and of the NSX. Authorized and regulated by ASIC.
All rights reserved. All material presented in this document, unless specifically indicated otherwise, is under copyright to Canaccord Genuity Corp., Canaccord Genuity Limited, Canaccord Genuity Inc or Canaccord Genuity Group Inc. None of the material, nor its content, nor any copy of it, may be altered in any way, or transmitted to or distributed to any other party, without the prior express written permission of the entities listed above.
